IRCT20191006044994N1 IRCT 2019-11-11 Iran University of Medical Sciences Effect of Rosa damascena on nonalcoholic fatty liver disease Comparison of the effect of Rosa damascena with placebo on liver enzymes in patients with nonalcoholic fatty liver disease(NAFLD): a double-blind randomized clinical trial 2019-11-19 anticipated 80 Complete https://irct.ir/trial/42819 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The block randomization method is used using 4-way blocks and a random number table.Interventions A and B define six blocks of four.Using random numbers, we select and write blocks. Each individual is then assigned to an A or B intervention. For allocation concealment, sealed envelopes are used, so that the individual number is written on the envelope and the treatment group inside the envelope, Blinding description: The drug and placebo are coded in similar capsules and in identical packages, with the same color and aroma, and the patient, clinician, and researcher are unaware of how the drug or placebo is coded. 2-3 Non Alcoholic Fatty Liver Disease. Intervention 1: Intervention group: 500 mg capsules of Rosa damascena,6 capsules per day ;each time 2 capsules(*3), Orally, For12 weeks. Intervention 2: Control group: Placebo (breadcrumbs), 500 mg capsule containing breadcrumbs, 6 capsules daily, three per day each time 2 capsules, orally for 12 weeks. No - There is not a plan to make this available Justification or reason for not sharing IPD is No more information.